The RAIQC AIM tool monitors and evaluates the performance of diagnostic AI tools on an ongoing basis, highlighting reporting discrepancies and ensuring they meet Trust expectations and AI Vendor claims.
Monitoring, or post-market surveillance, is vital in ensuring AI tools continue to perform safely and effectively after deployment.
Built in line with national guidance from the Royal College of Radiologists, RAIQC AIM provides an ongoing oversight of AI performance at patient, finding, and instrument level to highlight any discrepancies, bias, or performance drift over time.
The tool also allows monitoring of the impact of diagnostic AI on operational KPIs, such as the time from X-ray acquisition to follow-up; downstream investigations triggered by AI findings; and changes in detection and reporting patterns.
The RAIQC AIM tool:
The tool:
Designed as a vendor-neutral, platform-independent solution, the RAIQC AIM tool can be deployed on-premises or in the cloud and setup to accept data from multiple sources and systems.